As a member of Insulet’s Board of Directors and Audit Committee since January 2024, Ms. Pease has a deep understanding of the Company's strategy, operations, and financials. In connection with her ...

Medical device maker Insulet on Tuesday named former Charles River Laboratories executive Flavia Pease as its new chief financial officer, succeeding Ana Maria Chadwick effective 30.

Insulet ( (PODD) ) has provided an announcement. On September 16, 2025, Insulet Corporation announced the appointment of Flavia Pease as the new Chief Financial Officer, succeeding Ana Maria Chadwick ...

The event will include cooking demonstrations, informational booths and free and discounted screenings and immunizations.

Insulet Corporation ( NASDAQ: PODD) Baird Global Healthcare Conference 2025 September 9, 2025 12:15 PM EDT Jeff Johnson. I'm the Senior Medical Technology Analyst at Baird and our next presentation ...

Brands succeed by appealing to both the functional benefits of a product and a person’s identity and aspirations.

Strapping on an insulin pump may not always feel heroic, but Insulet and Marvel are changing that narrative with a new comic ...

PODD's 77.2% stock surge is fueled by Omnipod 5 expansion, global launches, strong Q2 profits and robust financial stability.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Eric Benjamin ...

What Happened: After conducting a thorough analysis, Singh sold 687 shares of Insulet. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Friday, September 12, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA ...